Acadia Pharmaceuticals Inc. ACAD
$28.24
-0.49%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | Insider transaction | 2026-08-07 | View → |
| 10-Q | 10-Q | 2026-08-05 | View → |
| 8-K | 8-K | 2026-08-04 | View → |
| 4 | Insider transaction | 2026-07-31 | View → |
| 4 | Insider transaction | 2026-06-29 | View → |
| 4 | 4 | 2026-06-02 | View → |
| 4 | Insider transaction | 2026-06-01 | View → |
| 4 | Insider transaction | 2026-06-01 | View → |
| 4 | Insider transaction | 2026-06-01 | View → |
| 4 | Insider transaction | 2026-06-01 | View → |
| 4 | Insider transaction | 2026-06-01 | View → |
| 4 | Insider transaction | 2026-06-01 | View → |
| 8-K | 8-K | 2026-05-29 | View → |
| 4 | Insider transaction | 2026-05-27 | View → |
| 10-Q | 10-Q | 2026-05-07 | View → |
| 8-K | 8-K | 2026-05-06 | View → |
| 4 | Insider transaction | 2026-05-05 | View → |
| 4 | Insider transaction | 2026-05-05 | View → |
| 8-K | 8-K | 2026-05-01 | View → |
| DEF 14A | DEF 14A | 2026-04-24 | View → |
| 4 | Insider transaction | 2026-04-07 | View → |
| 4 | Insider transaction | 2026-04-07 | View → |
| 4 | Insider transaction | 2026-03-26 | View → |
| 4 | Insider transaction | 2026-03-26 | View → |
| 4 | Insider transaction | 2026-03-26 | View → |
| 4 | Insider transaction | 2026-03-26 | View → |
| 4 | Insider transaction | 2026-03-26 | View → |
| 4 | Insider transaction | 2026-03-20 | View → |
| 4 | Insider transaction | 2026-03-10 | View → |
| 4 | Insider transaction | 2026-03-10 | View → |
| 4 | Insider transaction | 2026-03-10 | View → |
| 4 | Insider transaction | 2026-03-10 | View → |
| 4 | Insider transaction | 2026-03-10 | View → |
| 4 | Insider transaction | 2026-03-10 | View → |
| 8-K | 8-K | 2026-03-05 | View → |
| 10-K | 10-K | 2026-02-26 | View → |
| 8-K | 8-K | 2026-02-25 | View → |
| 4 | Insider transaction | 2026-02-10 | View → |
| 8-K | 8-K | 2026-01-13 | View → |
| 4 | Insider transaction | 2025-11-19 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $28.24
- Market Cap
- $5.07 billion
- 52-Week Range
- $19.69 – $29.85
- Average Volume
- 1.65 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.